Allianz Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-8,858
Closed -$551K – 2278
2023
Q4
$551K Buy
8,858
+1,758
+25% +$98.3K ﹤0.01% 1825
2023
Q3
$398K Sell
7,100
-2,530
-26% -$142K ﹤0.01% 2002
2023
Q2
$486 Sell
9,630
-2,700
-22% -$144K ﹤0.01% 2087
2023
Q1
$673K Sell
12,330
-2,174
-15% -$127K ﹤0.01% 1814
2022
Q4
$907K Buy
+14,504
New +$962K ﹤0.01% 1556
2022
Q3
– Sell
-62,844
Closed -$3.56M – 2168
2022
Q2
$3.56M Sell
62,844
-183,928
-75% -$10.1M ﹤0.01% 1218
2022
Q1
$15.4M Buy
246,772
+55,998
+29% +$3.02M 0.01% 839
2021
Q4
$10.7M Sell
190,774
-193,926
-50% -$11.9M 0.01% 975
2021
Q3
$25M Buy
384,700
+11,015
+3% +$752K 0.02% 644
2021
Q2
$23.7M Sell
373,685
-3,500
-0.9% -$207K 0.02% 579
2021
Q1
$22.6M Buy
377,185
+161,490
+75% +$8.78M 0.02% 579
2020
Q4
$10.8M Buy
215,695
+50,955
+31% +$2.39M 0.01% 817
2020
Q3
$8.41M Buy
164,740
+5,499
+3% +$230K 0.01% 822
2020
Q2
$5.59M Sell
159,241
-84,408
-35% -$2.91M 0.01% 1157
2020
Q1
$6.19M Buy
243,649
+88,435
+57% +$2.63M 0.01% 1055
2019
Q4
$4.3M Buy
+155,214
New +$3.7M ﹤0.01% 1554

Other funds holding AXNX

Allianz Asset Management's AXNX Position: Q1 2024 in Review

Allianz Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 8,858 shares — an estimated $551K sold.

Allianz Asset Management first reported a position in AXNX in Q4 2019 and held it in 16 quarters. The position peaked at $25M in Q3 2021. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Allianz Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Allianz Asset Management sold 8,858 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $551K.
  • Allianz Asset Management first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 16 quarters.
  • Allianz Asset Management's Axonics, Inc. Common Stock position peaked at $25M in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Allianz Asset Management's 13F filing for Q1 2024, filed 14 May 2024.